The Role of Post-treatment FDG-PET/CT Scanning after the First-line Chemotherapy in Predicting Prognosis in Patients with Hodgkin Disease and High-grade Non-Hodgkin Lymphoma: A Comparative Study with Clinical Prognostic Risk Scoring Data
BEZMIALEM SCIENCE, vol.10, no.3, pp.264-273, 2022 (ESCI, TRDizin)
- Publication Type: Article / Article
- Volume: 10 Issue: 3
- Publication Date: 2022
- Doi Number: 10.14235/bas.galenos.2021.5981
- Journal Name: BEZMIALEM SCIENCE
- Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Page Numbers: pp.264-273
- Keywords: Lymphoma, positron emission mography/computed tomography, F-18 fluorodeoxyglucose, clinical prognostic risk scores, POSITRON-EMISSION-TOMOGRAPHY, B-CELL LYMPHOMA, SUV-BASED ASSESSMENT, RESPONSE ASSESSMENT, F-18-FDG PET
- Open Archive Collection: AVESIS Open Access Collection
- Istanbul University Affiliated: No
Abstract
Objective: We aimed to evaluate the role of fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) performed after the first-line therapy in predicting prognosis of lymphomas and compare the results with the pretreatment prognostic risk scoring (PRS) indices.